Digest Network Come funziona
Network
/
Società
DB
Non verificato

DBV Technologies S.A.

Di cosa scriviamo

BiotecnologiaPolitica Internazionale

103 comunicati stampa

Guarda tutti i comunicati
04/03/2026
Biotecnologia
Politica Internazionale
DBV Technologies annonce sa participation à plusieurs conférences investisseurs en mars
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
04/03/2026
Biotecnologia
Politica Internazionale
DBV Technologies to Participate in Upcoming March Investor Conferences
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
03/03/2026
Biotecnologia
Politica Internazionale
Information relative au nombre total des droits de vote et d’actions composant le capital social au 28 février 2026
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
03/03/2026
Biotecnologia
Politica Internazionale
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
28/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies présente des données positives supplémentaires de l’étude de phase 3 VITESSE à l’occasion du congres annuel AAAAI
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
28/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
10/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
10/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies présentera des données complémentaires issues de l'étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans et discutera de l'avenir de l'EPIT lors du congrès annuel 2026 de l'AAAAI
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
09/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0
09/02/2026
Biotecnologia
Politica Internazionale
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
Fonte
DBV Technologies S.A.
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0